2008/185/EC: Commission Decision of 21 February 2008 on additional guarantees in intra-Community trade of pigs relating to Aujeszky’s disease and criteria to provide information on this disease (notified under document number C(2008) 669) (Codified version) (Text with EEA relevance)
Date: 2008-02-21
Institutions: European Commission
Subjects: animal disease, animal product, health control, intra-EU trade, swine, veterinary inspection

4.3.2008

EN

Official Journal of the European Union

L 59/19

COMMISSION

COMMISSION DECISION

of 21 February 2008
on additional guarantees in intra-Community trade of pigs relating to Aujeszky’s disease and criteria
to provide information on this disease

(notified under document number C(2008) 669)

(Codified version)

(Text with EEA relevance)

(2008/185/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

responsible for the establishment of international animal
health rules for trade in animals and animal products.
These rules are published in the International Animal
Health Code.

Having regard to the Treaty
Community,

establishing the European

Having regard to Council Directive 64/432/EEC of 26 June
1964 on animal health problems affecting intra-Community
trade in bovine animals and swine (1), and in particular
Article 8, Article 9(2) and Article 10(2) thereof,

Whereas:

(1)

Commission Decision 2001/618/EC of 23 July 2001 on
additional guarantees in intra-Community trade of pigs
relating to Aujeszky’s disease, criteria to provide infor-
mation on this
repealing Decisions
93/24/EEC and 93/244/EEC (2) has been substantially
amended several times (3). In the interests of clarity and
rationality the said Decision should be codified.

disease

and

(3)

The chapter of the International Animal Health Code on
Aujeszky’s disease has been substantially amended.

(4)

(5)

(6)

is appropriate to modify the additional guarantees
It
required in intra-Community trade of pigs in relation
to Aujeszky’s disease in order to ensure their consistency
with the international rules on this disease and better
control in the Community.

Criteria must be established on the information to be
provided by the Member States on Aujeszky’s disease,
in accordance with Article 8 of Directive 64/432/EEC.

The measures provided for
accordance with
Committee on the Food Chain and Animal Health,

in this Decision are in
Standing
the

opinion

the

of

(2)

is
The International Office of Epizootic Diseases (OIE)
the
the
international organisation designated under
Agreement on the Application of Sanitary and Phytosa-
nitary Measures in application of GATT 1994 which is

Article 1

HAS ADOPTED THIS DECISION:

(1) OJ 121, 29.7.1964, p. 1977/64. Directive as last amended by
Commission Decision 2007/729/EC (OJ L 294, 13.11.2007, p. 26).
(2) OJ L 215, 9.8.2001, p. 48. Decision as last amended by Decision

2007/729/EC.
(3) See Annex V.

The dispatching of pigs intended for breeding or production
destined for the Member States or regions free of Aujeszky’s
disease listed in Annex I and coming from any other Member
State or region not listed in that Annex is authorised subject to
the following conditions:

L 59/20

EN

Official Journal of the European Union

4.3.2008

1. Aujeszky’s disease must be compulsorily notifiable in the

Member State of origin;

(c) must have lived in the holding of origin or in a holding
of an equivalent status since birth, and have remained in
the holding of origin for at least:

2. a plan for the control and eradication of Aujeszky’s disease,
fulfilling the criteria laid down in Article 9(1) of Directive
64/432/EEC, must be in place in the Member State or
regions of origin under the supervision of the competent
authority. Appropriate measures on pig transport and
movements must be in place according to this plan for
preventing a spread of disease between holdings of a
different status;

3. with regard to the holding of origin of the pigs:

(a) no clinical, pathological or

serological evidence of
Aujeszky’s disease has been recorded in the previous
12 months in the holding in question;

(b) no clinical, pathological or

serological evidence of
Aujeszky’s disease has been recorded in the previous
12 months in the holdings located in an area of 5 km
surrounding the holding of origin of the pigs; however,
this provision shall not apply if, in these latter holdings,
disease monitoring and eradication measures have been
regularly applied under the supervision of the competent
authority and in accordance with the eradication plan
referred to in point (2), and these measures have effec-
tively prevented any spread of disease to the holding in
question;

(c) vaccination against Aujeszky’s disease has not been

carried out for at least 12 months;

(d) the pigs have been subjected on at least two occasions at
an interval of at least four months to a serological survey
for the presence of ADV-gE or ADV-gB or ADV-gD
antibody or to the whole Aujeszky’s disease virus. This
survey must have shown the absence of Aujeszky’s
disease and that vaccinated pigs have been free from
gE antibodies;

(e) no pigs have been introduced from holdings of a lower
animal health status as regards Aujeszky’s disease in the
previous 12 months, unless they have been tested for
Aujeszky’s disease with negative results;

4. the pigs to be moved:

(a) have not been vaccinated;

(i) 30 days, in the case of pigs intended for production;

(ii) 90 days, in the case of pigs intended for breeding;

(d) have been subjected with negative results to at least two
serological tests for ADV-gB or ADV-gD or the whole
Aujeszky’s disease virus, at a distance of at least 30 days
in case of pigs less than
between each test. However,
four months old, the serological test for ADV-gE may
also be used. Sampling for
test must be
performed within 15 days prior
to shipment. The
number of pigs tested in the isolation unit must be
sufficient to detect:

the last

(i) 2 % seroprevalence with 95 % confidence in the
isolation unit in case of pigs intended for production;

(ii) 0,1 % seroprevalence with 95 % confidence in the
isolation unit in case of pigs intended for breeding.

However, the first of the two tests shall not be necessary
if:

(i) in the framework of the plan referred to in point (2),
a serological survey has been carried out
in the
holding of origin between 45 and 170 days prior
of
to
Aujeszky’s disease antibodies and that vaccinated
pigs have been free from gE antibodies;

demonstrating

shipment,

absence

the

(ii) the pigs to be moved have lived in the holding of

origin since birth;

(iii) no pigs have moved on to the holding of origin
in
while the pigs to be moved have been kept
isolation.

Article 2

The dispatching of pigs intended for slaughter destined for the
Member States or regions free of Aujeszky’s disease listed in
Annex I and coming from any other Member State or region
not listed in that Annex, is authorised subject to the following
conditions:

1. Aujeszky’s disease must be compulsorily notifiable in the

Member State of origin;

(b) have been kept isolated in accommodation approved by
the competent authority, during the 30 days prior to
movement, and in such a way that any risk of
spreading Aujeszky’s disease to these pigs is prevented;

2. a plan for the control and eradication of Aujeszky’s disease is
in place in the Member State or regions of origin of the pigs,
fulfilling the criteria laid down in Article 1(2);

4.3.2008

EN

Official Journal of the European Union

L 59/21

3. all the pigs in question must be transported directly to the

2. come from:

slaughterhouse of destination and either:

(a)

they come from a holding which fulfils the conditions
laid down in Article 1(3); or

(b) they have been vaccinated against Aujeszky’s disease at
least 15 days prior to their shipment and come from a
holding of origin where:

(a) Member States or regions listed in Annex II; and

(b) a holding which fulfils the requirements of Article 1(3);

or

3. fulfil the following conditions:

(i) in the framework of the plan referred to in point (2),
eradication
the
the

Aujeszky’s
disease monitoring
measures have been regularly applied under
the competent authority for
supervision of
previous 12 months;

and

(ii) they had remained for at

least 30 days before
dispatch and where no clinical or pathological
evidence of this disease has been detected at
the
moment of completion of
the health certificate
referred to in Article 7; or

(c)

they have not been vaccinated and they proceed from a
holding where:

(i) in the framework of the plan referred to in point 2,
Aujeszky’s
eradication
disease monitoring
the
measures have been regularly applied under
supervision of
the competent authority in the
previous 12 months and no clinical, pathological
or serological evidence of Aujeszky’s disease has
been recorded in the previous six months;

and

(ii) vaccination against Aujeszky’s disease and intro-
duction of vaccinated pigs have been forbidden by
the competent authority, since the holding is in the
process of reaching the highest status as regards
Aujeszky’s disease
to the plan
referred to in point (2);

in accordance

(iii) they have lived for at least 90 days before dispatch.

(a) Aujeszky’s disease must be compulsorily notifiable in the

Member State of origin;

(b) a plan for the control and eradication of Aujeszky’s
disease is in place in the Member States or region of
origin, which fulfils the criteria laid down in Article 1(2);

(c) no clinical, pathological or

serological evidence of
Aujeszky’s disease has been recorded in the previous
12 months in the holding of origin of
the pigs in
question;

(d) the pigs must have been isolated in accommodation
approved by the competent authority for the 30 days
isolated in
immediately prior to movement and kept
such a way that any risk of spreading of Aujeszky’s
disease is prevented;

(e)

the pigs must have been subjected, with negative results,
to a serological test for the presence of gE antibodies.
Sampling for the last test must be performed within 15
days prior to shipment. The number of pigs tested must
to detect 2 % seroprevalence with 95 %
be sufficient
confidence in these pigs;

(f)

the pigs must have lived in the holding of origin or in a
holding of an equivalent status since birth, and have
remained in the holding of origin for at least 90 days.

Article 3

Article 4

Pigs intended for breeding destined for the Member States or
regions listed in Annex II, where approved Aujeszky’s disease
eradication programmes are in place, must either:

Pigs intended for production destined for the Member States or
regions listed in Annex II, where approved Aujeszky’s disease
eradication programmes are in place, must either:

1. come from Member States or regions listed in Annex I; or

1. come from Member States or regions listed in Annex I; or

L 59/22

EN

Official Journal of the European Union

4.3.2008

2. come from:

(a) Member States or regions listed in Annex II; and

(b) a holding which fulfils the requirements of Article 1(3);

or

3. fulfil the following conditions:

(a) Aujeszky’s disease must be compulsorily notifiable in the

Member State of origin;

(b) a plan for the control and eradication of Aujeszky’s
disease is in place in the Member States or region of
origin, which fulfils the criteria laid down in Article 1
point (2);

(c) no clinical, pathological or

serological evidence of
Aujeszky’s disease has been recorded in the previous
12 months in the holding of origin of
the pigs in
question;

(d) a serological survey for Aujeszky’s disease, demonstrating
its absence and that vaccinated pigs have been free from
gE antibodies, has been carried out in the holding of
origin and between 45 and 170 days prior to shipment;

(e)

the pigs must either have lived in the holding of origin
since birth or have remained in such holdings for at least
30 days after
introduction from a holding of an
equivalent status, where a serological survey equivalent
to the one referred to in point (d) has been carried out.

Article 5

section C of
64/432/EEC, the official veterinarian shall ascertain:

the health certificate required by Directive

(a)

the status of the holding and of the Member State or region
the pigs in question as regards Aujeszky’s
of origin of
disease;

(b) in case the pigs are not originating from a Member State or
a region free of the disease, the status of the holding and of
the Member State or regions of destination for the pigs in
question as regards Aujeszky’s disease;

(c)

the compliance of the pigs in question with the conditions
laid down in this Decision.

2.
For animals of the porcine species destined for Member
States or regions listed in Annex I or II, the certification under
paragraph 4 of Section C of the health certificate referred to in
paragraph 1 shall be completed and supplemented as follows:

(a)

in the first
indent, after
‘Aujeszky’ must be added;

the word ‘disease’

the word

(b) in the second indent,

reference shall be made to this
Decision. In the same line, the number of the Article of
this Decision, which is relevant for the pigs in question,
shall be quoted between brackets.

Article 8

Member States must ensure that when pigs destined for Member
States or regions listed in Annex I or II are transported, they
shall not come in contact with pigs of different or unknown
status, as regards Aujeszky’s disease, during transport or transit.

The serological tests carried out to monitor or detect Aujeszky’s
disease in pigs in accordance with this Decision must meet the
standards laid down in Annex III.

Article 9

Decision 2001/618/EC is repealed.

Article 6

the monitoring and eradication programmes

Without prejudice to Article 10(3) of Directive 64/432/EEC,
information on the occurrence of Aujeszky’s disease, including
details of
in
operation in the Member States listed in Annex II and in the
other Member States or regions not listed in that Annex where
monitoring and eradication programmes are in place, must be
provided at least annually by each Member State in accordance
with the uniform criteria laid down in Annex IV.

References to the repealed Decision shall be construed as
references to this Decision and shall be read in accordance
with the correlation table in Annex VI.

Article 10

This Decision is addressed to the Member States.

Article 7

Done at Brussels, 21 February 2008.

1. Without prejudice
laid down in
Community legislation concerning health certificates, before
the completion,
for animals of the porcine species destined
for Member States or regions listed in Annex I or II, of

to the provisions

For the Commission
The President

José Manuel BARROSO

4.3.2008

EN

Official Journal of the European Union

L 59/23

ANNEX I

Member States or regions thereof free of Aujeszky’s disease and where vaccination is prohibited

ISO code

Member State

Regions

CZ

DK

DE

FR

CY

LU

AT

SK

FI

SE

UK

Czech Republic

All regions

Denmark

Germany

France

All regions

All regions

The departments of Ain, Aisne, Allier, Alpes-de-Haute-Provence,
Alpes-Maritimes, Ardèche, Ardennes, Ariège, Aube, Aude, Aveyron,
Bas-Rhin, Bouches-du-Rhône, Calvados, Cantal, Charente, Charente-
Maritime, Cher, Corrèze, Côte-d’Or, Creuse, Deux-Sèvres, Dordogne,
Doubs, Drôme, Essonne, Eure, Eure-et-Loir, Gard, Gers, Gironde,
Hautes-Alpes, Hauts-de-Seine, Haute Garonne, Haute-Loire, Haute-
Marne, Hautes-Pyrénées, Haut-Rhin, Haute-Saône, Haute-Savoie,
Haute-Vienne, Hérault,
Jura, Landes,
Loire, Loire-Atlantique, Loir-et-Cher, Loiret, Lot, Lot-et-Garonne,
Lozère, Maine-et-Loire, Manche, Marne, Mayenne, Meurthe-et-
Moselle, Meuse, Moselle, Nièvre, Oise, Orne, Paris, Pas-de-Calais,
Pyrénées-Atlantiques, Pyrénées-Orientales, Puy-de-Dôme, Réunion,
Rhône,
Seine-
Maritime,
Tarn-et-Garonne,
Territoire de Belfort, Val-de-Marne, Val-d’Oise, Var, Vaucluse,
Vendée, Vienne, Vosges, Yonne, Yvelines

Seine-Saint-Denis,

Seine-et-Marne,

Saône-et-Loire,

Indre-et-Loire,

Somme,

Savoie,

Sarthe,

Indre,

Tarn,

Isère,

Cyprus

Whole territory

Luxembourg

All regions

Austria

Slovakia

Finland

Sweden

Whole territory

All regions

All regions

All regions

United Kingdom

All regions in England, Scotland and Wales

L 59/24

EN

Official Journal of the European Union

4.3.2008

ANNEX II

Member States or regions thereof where approved Aujeszky’s disease control programmes are in place

ISO code

Member State

Regions

BE

ES

FR

IT

NL

Belgium

Spain

France

Italy

Whole territory.

The territory of
Cantabria, Navarra, La Rioja.

the Autonomous Communities of Galicia, País Vasco, Asturias,

The territory of the provinces of León, Zamora, Palencia, Burgos, Valladolid and Ávila in
the Autonomous Community of Castilla y León.

The territory of the province of Las Palmas in the Canary Islands.

The departments of Côtes-d’Armor, Finistère, Ille-et-Vilaine, Morbihan and Nord.

The Province of Bolzano.

Netherlands

Whole territory.

4.3.2008

EN

Official Journal of the European Union

L 59/25

ANNEX III

Standards for Aujeszky’s disease serological tests — Protocol for the enzyme linked immunosorbent assay
(ELISA) for detecting antibodies to Aujeszky’s disease virus (whole virus), to glycoprotein B (ADV-gB), to
glycoprotein D (ADV-gD) or to glycoprotein E (ADV-gE)

1. The institutes listed in paragraph 2(d) shall evaluate Elisa ADV-gE tests and kits against the criteria in paragraph 2(a),
(b) and (c). The competent authority in each Member State shall ensure that only Elisa ADV-gE kits that meet these
standards shall be registered. The examinations listed in 2(a) and (b) must be carried out prior to approval of the test
and the examination in 2(c), at least, must thereafter be carried out on each batch.

2. Standardisation, sensitivity and specificity of the test.

(a) The sensitivity of the test must be of such a level that the following Community reference sera are scored positive:

— Community reference serum ADV 1 at 1:8 dilution,

— Community reference serum ADV-gE A,

— Community reference serum ADV-gE B,

— Community reference serum ADV-gE C,

— Community reference serum ADV-gE D,

— Community reference serum ADV-gE E,

— Community reference serum ADV-gE F.

(b) The specificity of the test must be of such a level that the following Community reference sera are scored negative:

— Community reference serum ADV-gE G,

— Community reference serum ADV-gE H,

— Community reference serum ADV-gE J,

— Community reference serum ADV-gE K,

— Community reference serum ADV-gE L,

— Community reference serum ADV-gE M,

— Community reference serum ADV-gE N,

— Community reference serum ADV-gE O,

— Community reference serum ADV-gE P,

— Community reference serum ADV-gE Q.

(c) For batch control, Community reference serum ADV 1 must be scored positive at 1:8 dilution and one of the

Community reference sera from ADV-gE G to ADV-gE Q, as listed in point (b), must be scored negative.

For batch control of ADV-gB and ADV-gD kits, Community reference serum ADV 1 must be scored positive at the
dilution of 1:2 and Community reference serum Q referred to in (b) should be scored negative.

(d) The institutes listed below will, in addition, be responsible for checking the quality of the ELISA method in each
Member State, and in particular for producing and standardising national reference sera according to the
Community reference sera.

L 59/26

EN

AT

BE

CY

CZ

DE

DK

EE

ES

FI

FR

UK

GR

Official Journal of the European Union

4.3.2008

AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für vete-
rinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection —
Institute for veterinary investigations Mödling)
Robert Koch-Gasse 17
A-2340 Mödling
Tel. +43 (0) 505 55-38112
Fax +43 (0) 505 55-38108
E-mail: vetmed.moedling@ages.at

CODA — CERVA — VAR
Veterinary and Agrochemical Research Centre
Groeselenberg 99
B-1180 Brussels

State Veterinary Laboratory
Veterinary Services
1417 Athalassa
Nicosia

—

Friedrich-Loeffler-Institut
Bundesforschungsinstitut für Tiergesundheit
Standort Wusterhausen
Seestraße 55
D-16868 Wusterhausen
Tel. + 49 33979 80-0
Fax + 49 33979 80-200

National Veterinary Institute, Technical University of Denmark
Lindholm
DK-4771 Kalvehave

Veterinaar- ja Toidulaboratoorium
Kreutzwaldi 30, 51006 Tartu, Estonia
Tel. + 372 7 386 100
Faks: + 372 7 386 102
E-mail: info@vetlab.ee

Laboratorio Central de Sanidad Animal de Algete
Carretera de Algete, km 8
Algete 28110 (Madrid)
Tel. +34 916 290 300
Fax +34 916 290 598
E-mail: lcv@mapya.es

Finnish Food Safety Authority
Animal Diseases and Food Safety Research
Mustialankatu 3
FI-00790 Helsinki, Finland
E-mail: info@evira.fi
Tel. +358 20 772 003 (exchange)
Fax +358 20 772 4350

Laboratoire d’études et de recherches avicoles, porcines et piscicoles
AFSSA site de Ploufragan/Brest —
LERAPP
BP 53
22440 Ploufragan

Veterinary Laboratories Agency
New Haw, Addlestone, Weybridge
Surrey KT15 3NB, UK
Tel. (44-1932) 341111
Fax (44-1932) 347046

Centre of Athens Veterinary Institutes
25 Neapoleos Street,
GR-153 10 Agia Paraskevi Attiki
Tel. +30 2106010903

4.3.2008

EN

HU

IE

IT

LT

LU

LV

MT

NL

PL

PT

SE

SI

SK

Official Journal of the European Union

L 59/27

Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság
Central Agricultural Office, Veterinary Diagnostic Directorate
Address: 1149 Budapest, Tábornok u. 2.
Mailing Address: 1581 Budapest, 146. Pf. 2.
Tel. +36 1 460-6300
Fax +36 1 252-5177
E-mail: titkarsag@oai.hu

Virology Division
Central Veterinary Research Laboratory
Department of Agriculture and Food Laboratories
Backweston Campus
Stacumny Lane
Celbridge
Co. Kildare

Centro di referenza nazionale per la malattia di Aujeszky —
Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna,
Via Bianchi, 9;
25124 Brescia

National Veterinary Laboratory
(Nacionalinė veterinarijos laboratorija)
J. Kairiūkščio 10
LT-08409 Vilnius

CODA — CERVA — VAR
Veterinary and Agrochemical Research Centre
Groeselenberg 99
B-1180 Brussels

Nacionālais diagnostikas centrs
(National Diagnostic Centre)
Lejupes iela 3, Rīga, LV-1076
Tel. +371 7620526
Fax +371 7620434
E-mail: ndc@ndc.gov.lv

—

Centraal Instituut voor Dierziekte Controle
CIDC-Lelystad
Hoofdvestiging: Houtribweg 39
Nevenvestiging: Edelhertweg 15
Postbus 2004
8203 AA Lelystad

Laboratory Departement of Swine Diseases
Państwowy Instytut Weterynaryjny – Państwowy Instytut
Badawczy
al. Partyzantów 57, 24-100 Puławy
Tel. +48 81 889 30 00
Fax +48 81 886 25 95
E-mail: sekretariat@piwet.pulawy.pl

Laboratório Nacional de Investigação Veterinária (LNIV)
Estrada de Benfica, 701
P-1549-011 Lisboa

Statens veterinärmedicinska anstalt
Department of Virology
S-751 89 Uppsala
Tel. (46-18) 67 40 00
Fax (46-18) 67 44 67

Univerza v Ljubljani
Veterinarska fakulteta
Nacionalni veterinarski inštitut
Gerbičeva 60,
SI-1000 Ljubljana

Štátny veterinárny ústav
Pod dráhami 918
960 86 Zvolen
Slovenska republika

L 59/28

EN

Official Journal of the European Union

4.3.2008

ANNEX IV

Criteria on the information to be provided on the occurrence of Aujeszky’s disease (AD) and on plans for the
monitoring and eradication of this disease, to be provided in accordance with Article 8 of Council Directive
64/432/EEC

1. Member State:

..................................................................................................................................................................................................

2. Date:

....................................................................................................................................................................................................................

3. Reporting period:

............................................................................................................................................................................................

4. Number of holdings where AD has been detected by means of clinical, serological or virological investigations:

......

5. Information on AD vaccination, serological investigations and categorisation of holdings (please complete the attached

table):

Region

Number of pig
holdings

Number of pig
holdings under an
AD-pogramme (1)

Number of AD
not-infected pig holdings
(with vaccination) (2)

Number of AD
free pig holdings
(without vaccination) (3)

Total

(1) Programme under the supervision of the competent authority.
(2) Pig holdings where serological tests for AD have been carried out with negative results in accordance with an official AD

programme and where vaccination has been applied during the previous 12 months.

(3) Pig holdings which fulfil the conditions of Article 1(3).

6. Further information on serological monitoring in Artificial

framework of other surveillance schemes, etc.:

in the
.....................................................................................................................................

Insemination Centres,

for export purposes,

................................................................................................................................................................................................................................

................................................................................................................................................................................................................................

................................................................................................................................................................................................................................

4.3.2008

EN

Official Journal of the European Union

L 59/29

ANNEX V

REPEALED DECISION WITH LIST OF ITS SUCCESSIVE AMENDMENTS

Commission Decision 2001/618/EC
(OJ L 215, 9.8.2001, p. 48).

Commission Decision 2001/746/EC
(OJ L 278, 23.10.2001, p. 41).

Commission Decision 2001/905/EC
(OJ L 335, 19.12.2001, p. 22).

Commission Decision 2002/270/EC
(OJ L 93, 10.4.2002, p. 7).

Commission Decision 2003/130/EC
(OJ L 52, 27.2.2003, p. 9).

Commission Decision 2003/575/EC
(OJ L 196, 2.8.2003, p. 41).

Commission Decision 2004/320/EC
(OJ L 102, 7.4.2004, p. 75).

Commission Decision 2005/768/EC
(OJ L 290, 4.11.2005, p. 27).

Commission Decision 2006/911/EC
(OJ L 346, 9.12.2006, p. 41).

Commission Decision 2007/603/EC
(OJ L 236, 8.9.2007, p. 7).

Commission Decision 2007/729/EC
(OJ L 294, 13.11.2007, p. 26).

Only as regards the reference to Decision 2001/618/EC
in Article 1

Only as regards the reference to Decision 2001/618/EC
in Article 2

Only Article 3

Only Article 2 and Annex II

Only as regards the reference to Decision 2001/618/EC
in Article 1 and point 12 of the Annex

Only as regards the reference to Decision 2001/618/EC
in Article 1 and point 10 of the Annex

L 59/30

EN

Official Journal of the European Union

4.3.2008

ANNEX VI

Correlation table

Decision 2001/618/EC

This Decision

Article 1(a) and (b)

Article 1, points 1 and 2

Article 1(c) first to fifth indent

Article 1, point 3(a) to (e)

Article 1(d) first to fourth indent

Article 1, point 4(a) to (d)

Article 2(a) and (b)

Article 2, points 1 and 2

Article 2(c) first to third indent

Article 2, point 3(a) to (c)

Article 3(a)

Article 3, point 1

Article 3(b) first and second indent

Article 3, point 2(a) and (b)

Article 3(c) first to sixth indent

Article 3, point 3(a) to (f)

Article 4(a)

Article 4, point 1

Article 4(b) first and second indent

Article 4, point 2(a) and (b)

Article 4(c) first to fifth indent

Article 4, point 3(a) to (e)

Articles 5 to 8

Articles 5 to 8

Article 9

Article 10

—

Article 11

Annexes I to IV

—

—

—

—

Article 9

Article 10

Annexes I to IV

Annex V

Annex VI